JO
RPTP

John Overdeck’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

John Overdeck’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-13,341
Closed -$81K – 3225
2015
Q3 		$81K Sell
13,341
-161,597
-92% -$1.98M ﹤0.01% 2084
2015
Q2 		$2.76M Buy
+174,938
New +$2.12M 0.01% 1023

Other funds holding RPTP

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

John Overdeck's RPTP Position: Q4 2015 in Review

John Overdeck sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2015, closing a stake of 13,341 shares — an estimated $81K sold.

John Overdeck first reported a position in RPTP in Q2 2015 and held it in 2 quarters. The position peaked at $2.76M in Q2 2015. 108 funds tracked by Wall St. Rank hold RPTP as of Q4 2015.

  • John Overdeck reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2015 after selling out during the quarter.
  • John Overdeck sold 13,341 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2015, an estimated $81K.
  • John Overdeck first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2015 and held it in 2 quarters.
  • John Overdeck's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $2.76M in Q2 2015.
  • 108 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2015.

Based on Two Sigma Investments's 13F filing for Q4 2015, filed 16 Feb 2016.